Breast cancer proliferative activity: Is it the source of serum free DNA?

被引：2
|
作者：
Hewala, Taha I. [1 ]
El-Moneim, Nadia A. Abd [2 ]
机构：
[1] Alexandria Univ, Med Res Inst, Dept Radiat Sci, 165 Horria Ave,El Hadara, Alexandria 21561, Egypt
[2] Alexandria Univ, Med Res Inst, Dept Canc Management & Res, Alexandria 21561, Egypt
来源：
ALEXANDRIA JOURNAL OF MEDICINE | 2013年 / 49卷 / 04期
关键词：
Breast cancer; Proliferative activity; Diagnosis; Prognosis; DNA; TPS; CEA;
D O I：
10.1016/j.ajme.2013.03.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aim: To study the relationship between serum DNA and breast cancer proliferative activity, then compare the diagnostic and prognostic values of serum DNA, TPS and CEA. Subjects and methods: A total of 100 breast cancer patients before surgery and 50 apparently healthy controls were analyzed for serum DNA, TPS and CEA. Results: Serum DNA levels were nonsignificantly correlated with serum TPS levels. Serum DNA, TPS and CEA levels were significantly higher in patients than controls. Using ROC curve analysis, serum TPS and DNA had the highest AUC compared to serum CEA. Neither serum TPS, DNA nor CEA correlated with breast cancer clinicopathological data. Only serum CEA was significantly correlated with patients' disease-free survival. Conclusion: Neither Breast cancer mass nor proliferative activity is the source of serum free DNA. Serum TPS is superior to DNA and CEA as a diagnostic marker for breast cancer. Only preoperative serum CEA has a prognostic role in predicting relapse of breast cancer patients, but not serum TPS or DNA. (C) 2013 Production and hosting by Elsevier B.V. on behalf of Alexandria University Faculty of Medicine.
引用
收藏
页码：337 / 341
页数：5
相关论文
共 50 条
  • [31] BIOLOGICAL CORRELATION BETWEEN HER-2/NEU AND PROLIFERATIVE ACTIVITY IN HUMAN BREAST-CANCER
    TOMMASI, S
    PARADISO, A
    MANGIA, A
    BARLETTA, A
    SIMONE, G
    SLAMON, DJ
    DELENA, M
    ANTICANCER RESEARCH, 1991, 11 (04) : 1395 - 1400
  • [32] Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer
    Neri, A.
    Marrelli, D.
    Pedrazzani, C.
    Caruso, S.
    De Stefano, A.
    Mariani, F.
    Megha, T.
    De Marco, G.
    Corso, G.
    Pinto, E.
    Roviello, F.
    EJSO, 2008, 34 (12): : 1299 - 1303
  • [33] Proliferative index obtained by DNA image cytometry -: Does it add prognostic information in Auer IV breast cancer?
    Baldetorp, B
    Fernö, M
    Bendahl, PO
    Fallenius, G
    Idvall, I
    Åkerman, M
    Killander, D
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1998, 20 (02): : 144 - 152
  • [34] Serum vascular endothelial growth factor in breast cancer
    Byrne, G. J.
    McDowell, G.
    Agarawal, R.
    Sinha, G.
    Kumar, S.
    Bundred, N. J.
    ANTICANCER RESEARCH, 2007, 27 (5B) : 3481 - 3487
  • [35] Methylated DNA and Total DNA in Serum Detected by One-Step Methylation-Specific PCR Is Predictive of Poor Prognosis for Breast Cancer Patients
    Fujita, Noriko
    Nakayama, Takahiro
    Yamamoto, Noriaki
    Kim, Seung Jin
    Shimazu, Kenzo
    Shimomura, Atsushi
    Maruyama, Naomi
    Morimoto, Koji
    Tamaki, Yasuhiro
    Noguchi, Shinzaburo
    ONCOLOGY, 2012, 83 (05) : 273 - 282
  • [36] Tissue Microarray Technique in Evaluation of Proliferative Activity in Invasive Ductal Breast Cancer
    Kobierzycki, Christopher
    Pula, Bartosz
    Wojnar, Andrzej
    Podhorska-Okolow, Marzena
    Dziegiel, Piotr
    ANTICANCER RESEARCH, 2012, 32 (03) : 773 - 777
  • [37] IMMUNOHISTOCHEMICAL QUANTITATION OF ESTROGEN-RECEPTORS AND PROLIFERATIVE ACTIVITY IN ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER
    JENSEN, V
    LADEKARL, M
    JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (05) : 429 - 432
  • [38] The Discovery of Potent SHP2 Inhibitors with Anti-Proliferative Activity in Breast Cancer Cell Lines
    Ghemrawi, Rose
    Khair, Mostafa
    Hasan, Shaima
    Aldulaymi, Raghad
    AlNeyadi, Shaikha S.
    Atatreh, Noor
    Ghattas, Mohammad A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [39] Clinical Value of Nipple Discharge and Serum Markers of Breast Cancer
    Liang, Yun'ai
    Mou, Zongling
    Zhang, Jie
    Li, Xin
    Chen, Ying
    Wang, Gangping
    PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON MECHANICAL SCIENCE AND ENGINEERING, 2016, 66
  • [40] Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
    Hashad, D.
    Sorour, A.
    Ghazal, A.
    Talaat, I.
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2012, 26 (06) : 467 - 472
12345